spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Mobile-Optimised Continuous Monitoring System from Vaisala Enhances Product Safety

Vaisala Ltd


Vaisala has launched viewLinc 4.0, a new version of its monitoring, alarming and reporting software, which is the heart of the Vaisala Continuous Monitoring System. Aimed at highly demanding controlled and regulated environments in the pharmaceutical and biotechnology industries, the new version offers an optimized mobile interface for remote monitoring and alarm management. This, along with the location-based reporting and data logging capability, allows users to act on alarms immediately, anywhere and anytime on their smart phones, to improve product safety and ensure compliance with GMP and other regulations.

Other key features include a greatly enhanced user interface that is easier to navigate and more customization capabilities in historical reports and live multiple-channel trend display for enhanced reporting. Users can now create reports more quickly in preparation for and during field quality audits.

"We are ecstatic with the Vaisala viewLinc Monitoring System! It not only helps us meet FDA regulatory and accreditation requirements, but we can now monitor multiple sites from any location," states Brad Bayette, Tissue Services Manager at US-based tissue bank.

The improved user interface facilitates easy access to product data in a more familiar Windows-type navigation. In addition, it shows data by location, which allows users to easily find their loggers, swap out devices, and report data by location. With the mobile interface, users can acknowledge and pause alarms, view live trends on any monitored location under their control, and view trend data in real-time.

"Like its predecessors, Vaisala viewLinc 4.0 is easily deployed for monitoring temperature, relative humidity, CO2, differential pressure, level, door switches, and more. But, we built this version of viewLinc based on working closely with viewLinc users. Every new feature and interface capability came from feedback and suggestions we got. viewLinc 4.0 addresses the changing needs of our customers and integrates new technologies and user expectations, such as drag and drop and mobile usage," says Jon Aldous, Product Manager for Vaisala's Life Science business.

Vaisala will offer its customers warranty, software upgrades, technical support and user training services. Language localized versions will be available in May 2012 in French, Chinese, German and Japanese.
phone +44 (0) 121 683 5620
email uksales@vaisala.com
web www.vaisala.com/lifescience
email Bury St Edmunds Office, Unit 2b Hillside Business Park, Kempson Way, Bury St Edmunds, Suffolk, IP32 7EA
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Mironid Announces Closing of £4.3 million ($6.2 million) Series A Financing

Cell signalling in drug development company today announced the closure of its Series A funding round
More info >>


White Papers

Bonfiglioli Engineering Headspace Gas Analysis Systems for Parenteral Manufacturing Processes: One Step Beyond Product Quality and Patient Safety

Bonfiglioli Engineering

This white paper presents the innovative solutions that Bonfiglioli Engineering has been developing in the field of HGA and their significant advantages over other existing systems.
More info >>

Industry Events

all4pack

14-17 November 2016, Paris Nord Villepinte, France

In light of increasing integration along the entire production chain, the EMBALLAGE and MANUTENTION exhibitions have confirmed their complementary nature by becoming ALL4PACK Paris, the global marketplace for Packaging, Processing, Printing & Handling. This marks a strategic move in response to buyers’ expectations and reinforces the event’s key position for the EMEA region at an international level. With 6 months to go before ALL4PACK Paris opens, the new setup is attracting attention and registration numbers are rising.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement